{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:01:16Z","timestamp":1792598476940,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare the cumulative live birth rate (CLBR) of a gonadotropin-releasing hormone (GnRH) antagonist regimen and a progestin-primed ovarian stimulation (PPOS) regimen in low-prognosis patients according to POSEIDON criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Single-center, retrospective, observational study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Henan Provincial People\u2019s Hospital, Zhengzhou, China<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Women aged \u226440 years, with a body mass index &amp;lt;25 kg\/m<jats:sup>2<\/jats:sup>, who underwent <jats:italic>in vitro<\/jats:italic> fertilization (IVF) or intracytoplasmic sperm microinjection (ICSI) and met POSEIDON low-prognosis criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>GnRH or PPOS regimen with IVF or ICSI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measure<\/jats:title><jats:p>CLBR per oocyte retrieval cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Per oocyte retrieval cycle, CLBR was significantly higher with GnRH antagonist versus PPOS (35.3% vs 25.2%; P&amp;lt;0.001). In multivariable logistic regression analysis, CLBR per oocyte retrieval cycle was significantly lower with PPOS versus GnRH antagonist before (OR 0.62 [95% confidence intervals (CI): 0.46, 0.82; P=0.009]) and after (OR 0.66 [95% CI: 0.47, 0.93; P=0.0172]) adjustment for age, body mass index, infertility type, infertility duration, baseline follicle stimulating hormone, anti-M\u00fcllerian hormone (AMH), antral follicle count (AFC), and insemination method. CLBR was numerically higher with the GnRH antagonist regimen than with PPOS, across all of the POSEIDON groups, and was significantly higher in patients aged \u226535 years with poor ovarian reserve [AFC &amp;lt;5, AMH &amp;lt;1.2 ng\/mL] (unadjusted, P=0.0108; adjusted, P=0.0243).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this single-center, retrospective, cohort study, patients had a higher CLBR with a GnRH antagonist versus PPOS regimen, regardless of other attributes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.644456","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T15:43:09Z","timestamp":1624290189000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Shaodi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisha","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11525.x","article-title":"Assisted Conception Following Poor Ovarian Response to Gonadotrophin Stimulation","volume":"104","author":"Keay","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/352098","article-title":"Management of Poor Responders in IVF: Is There Anything New","volume":"2014","author":"Ubaldi","year":"2014","journal-title":"BioMed Res Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062110","article-title":"Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations","volume":"21","author":"Abu-Musa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2015.03.002","article-title":"How to Define, Diagnose and Treat Poor Responders? Responses From a Worldwide Survey of IVF Clinics","volume":"30","author":"Patrizio","year":"2015","journal-title":"Reprod BioMed Online"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE Consensus on the Definition of \u2018Poor Response\u2019 to Ovarian Stimulation for In Vitro Fertilization: The Bologna Criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu139","article-title":"The Bologna Criteria for the Definition of Poor Ovarian Responders: Is There a Need for Revision","volume":"29","author":"Ferraretti","year":"2014","journal-title":"Hum Reprod"},{"key":"B7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13048-015-0204-9","article-title":"The Bologna Criteria for Poor Ovarian Response: A Contemporary Critical Appraisal","volume":"8","author":"Younis","year":"2015","journal-title":"J Ovarian Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria - The Why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.03.009","article-title":"Live Birth Rates in Various Subgroups of Poor Ovarian Responders Fulfilling the Bologna Criteria","volume":"34","author":"Bozdag","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu319","article-title":"A Retrospective Evaluation of Prognosis and Cost-Effectiveness of IVF in Poor Responders According to the Bologna Criteria","volume":"30","author":"Busnelli","year":"2015","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0476-4","article-title":"Live Birth Rates in the Different Combinations of the Bologna Criteria Poor Ovarian Responders: A Validation Study","volume":"32","author":"La Marca","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A New More Detailed Stratification of Low Responders to Ovarian Stimulation: From a Poor Ovarian Response to a Low Prognosis Concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","article-title":"The Novel POSEIDON Stratification of \u2018Low Prognosis Patients in Assisted Reproductive Technology\u2019 and its Proposed Marker of Successful Outcome","volume":"5","author":"Humaidan","year":"2016","journal-title":"F1000Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s13063-018-2850-x","article-title":"Gonadotropin-Releasing Hormone Antagonist Versus Progestin for the Prevention of Premature Luteinising Hormone Surges in Poor Responders Undergoing In Vitro Fertilisation Treatment: Study Protocol for a Randomised Controlled Trial","volume":"19","author":"Wang","year":"2018","journal-title":"Trials"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-20","article-title":"Optimal Usage of the GnRH Antagonists: A Review of the Literature","volume":"11","author":"Copperman","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of Progestins to Inhibit Spontaneous Ovulation During Ovarian Stimulation: The Beginning of a New Era","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod BioMed Online"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw047","article-title":"New Stimulation Regimens: Endogenous and Exogenous Progesterone Use to Block the LH Surge During Ovarian Stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled Ovulation of the Dominant Follicle Using Progestin in Minimal Stimulation in Poor Responders","volume":"15","author":"Chen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1038\/s41598-017-07773-w","article-title":"Effect of Frozen Embryo Transfer and Progestin-Primed Ovary Stimulation on IVF Outcomes in Women With High Body Mass Index","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial","volume":"95","author":"Wang","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B21","article-title":"Application of Three Kinds of Ovulation Induction in In Vitro Fertilization\/Intracytoplasmic Sperm Injection Patients With Poor Ovarian Response","volume":"3","author":"Lijun","year":"2018","journal-title":"Chin J Reprod Contracept"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g14","article-title":"First Trimester Fetal Growth Restriction and Cardiovascular Risk Factors in School Age Children: Population Based Cohort Study","volume":"348","author":"Jaddoe","year":"2014","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.jogoh.2019.101661","article-title":"Ovulation Induction With High Progesterone Levels may be More Suitable for Elderly Patients With Low Ovarian Response","volume":"50","author":"Mu","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","article-title":"Progestin-Primed Ovarian Stimulation is a Feasible Method for Poor Ovarian Responders Undergoing in IVF\/ICSI Compared to a GnRH Antagonist Protocol: A Retrospective Study","volume":"48","author":"Huang","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH Agonist Long Protocol Versus GnRH Antagonist Protocol for Various Aged Patients With Diminished Ovarian Reserve: A Retrospective Study","volume":"13","author":"Huang","year":"2018","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing In Vitro Fertilization Treatment: A Randomized Controlled Trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","article-title":"Suggestions of Chinese Experts on the Diagnosis and Treatment of Low-Prognosis Patients Undergoing Assisted Reproductive Technology: A Delphi Analysis. In Chinese","volume":"40","year":"2020","journal-title":"Chin J Reprod Contracep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00409","article-title":"Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles","volume":"10","author":"Shi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00642","article-title":"Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of In Vitro Fertilization\/Intracytoplasmic Sperm Injection","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der106","article-title":"Association Between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte Number as a Predictor for Ovarian Hyperstimulation Syndrome and Live Birth: An Analysis of 256,381 In Vitro Fertilization Cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"B32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-020-00574-3","article-title":"Cumulative Live Birth Rates According to the Number of Oocytes Retrieved Following the \u201cFreeze-All\u201d Strategy","volume":"18","author":"Zhao","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.05.021","article-title":"Total Number of Oocytes and Zygotes are Predictive of Live Birth Pregnancy in Fresh Donor Oocyte In Vitro Fertilization Cycles","volume":"108","author":"Hariton","year":"2017","journal-title":"Fertil Steril"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00067","article-title":"The Future of Cryopreservation in Assisted Reproductive Technologies","volume":"11","author":"Bosch","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw007","article-title":"Oocyte Cryopreservation: Where are We Now","volume":"22","author":"Argyle","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cryobiol.2020.03.010","article-title":"Type of Protein Supplement in Cryopreservation Solutions Impacts on the Degree of Ultrastructural Damage in Frozen-Thawed Human Oocytes","volume":"95","author":"De Santis","year":"2020","journal-title":"Cryobiology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4856-8","article-title":"New Trial of Progestin-Primed Ovarian Stimulation Using Dydrogesterone Versus a Typical GnRH Antagonist Regimen in Assisted Reproductive Technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v17i9.5103","article-title":"Progesterone-Primed Ovarian Stimulation in Polycystic Ovarian Syndrome: An Rct","volume":"17","author":"Eftekhar","year":"2019","journal-title":"Int J Reprod BioMed"},{"key":"B39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for Pituitary Suppression During Ovarian Stimulation for ART: A Comprehensive and Systematic Review Including Meta-Analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.12.032","article-title":"Female Obesity Impairs In Vitro Fertilization Outcome Without Affecting Embryo Quality","volume":"93","author":"Bellver","year":"2010","journal-title":"Fertil Steril"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-012-4357-0","article-title":"Effect of Maternal Age on the Outcomes of In Vitro Fertilization and Embryo Transfer (IVF-ET)","volume":"55","author":"Yan","year":"2012","journal-title":"Sci China Life Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz011","article-title":"Female Obesity is Negatively Associated With Live Birth Rate Following IVF: A Systematic Review and Meta-Analysis","volume":"25","author":"Semondade","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B43","article-title":"Overweight and Obesity Adversely Affect Outcomes of Assisted Reproductive Technologies in Polycystic Ovary Syndrome Patients","volume":"6","author":"Bu","year":"2013","journal-title":"Int J Clin Exp Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.644456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T15:43:16Z","timestamp":1624290196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.644456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":43,"alternative-id":["10.3389\/fendo.2021.644456"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.644456","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"article-number":"644456"}}